Ardelyx Inc banner

Intrinsic Value

The intrinsic value of Ardelyx Inc (ARDX) under the Base Case is 9.302 USD per share. Compared with the current market price of 3.035 USD, the stock appears Undervalued by 67% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

ARDX Intrinsic Value
$9.302
Undervaluation 67%
Intrinsic Value
Price $3.035

ARDX is cheaper than usual. It was this cheap or cheaper on just 7% of days in the past 5 years.

Monitor ARDX
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $7.44
Get notified when the price drops into your buy zone
Intrinsic Value $9.3
Margin of Safety 20% $7.44
Current Price $3.04
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to ARDX

Fundamental Analysis

What Ardelyx Does

Biotechnology Health Care

Ardelyx is a biopharmaceutical company focused on medicines for gastrointestinal and kidney-related conditions. Its main products are prescription drugs that help treat problems like constipation from certain causes and help control phosphate levels in people with chronic kidney disease. The company does not sell consumer goods; it develops and commercializes specialized therapies for doctors to prescribe.

Headquarters
United States of America US
Employees
489
IPO date
Jun 19, 2014
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Ardelyx Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

ARDX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ARDX stock?

The intrinsic value for Ardelyx Inc (ARDX) under the Base Case is 9.302 USD.

Is ARDX stock undervalued or overvalued?

Compared with the current market price of 3.035 USD, the stock appears Undervalued by 67% .

Back to Top